These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7961004)

  • 81. Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical cancer with radiotherapy.
    Bonin SR; Lanciano RM; Corn BW; Hogan WM; Hartz WH; Hanks GE
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):167-72. PubMed ID: 12118547
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Standard versus individually planned irradiation field in radiotherapy of infradiaphragmatic lymph node sites].
    Nevinny-Stickel M; Ennemoser S; Bangerl I; zur Nedden D; Lukas P
    Strahlenther Onkol; 1998 Jul; 174(7):341-4. PubMed ID: 9689953
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Comparison of standard and individually planned infradiaphragmatic fields in irradiation of retroperitoneal lymph nodes.
    Nevinny-Stickel M; Ennemoser S; Sweeney R; Bangerl I; Zur Nedden D; Lukas P
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):147-51. PubMed ID: 10924984
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Use of CT simulation for treatment of cervical cancer to assess the adequacy of lymph node coverage of conventional pelvic fields based on bony landmarks.
    Finlay MH; Ackerman I; Tirona RG; Hamilton P; Barbera L; Thomas G
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):205-9. PubMed ID: 16198505
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The role of lymphangiography in designing fields for elective pelvic node irradiation in Hodgkin's disease.
    Mendenhall NP; Holland KW; Sombeck MD
    Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):993-5. PubMed ID: 7961004
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).
    Sargos P; Guerif S; Latorzeff I; Hennequin C; Pommier P; Lagrange JL; Créhange G; Chapet O; de Crevoisier R; Azria D; Supiot S; Habibian M; Soulié M; Richaud P
    Cancer Treat Rev; 2015 Dec; 41(10):814-20. PubMed ID: 26508669
    [TBL] [Abstract][Full Text] [Related]  

  • 87.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 88.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 89.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 90.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 91.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.